跳至主要内容
临床试验/SLCTR/2018/030
SLCTR/2018/030尚未招募3 期

Oxidative stress in Chronic Kidney Disease of unknown aetiology (CKDu) and the efficacy and safety of vitamin C and vitamin E in slowing the progression of early stages of CKDu in Sri Lanka. – A Double Blinded Placebo Controlled Randomized Clinical Trial

niversity of Colombo, Sri Lanka0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male and female patients aged between 18 and 45 years
  • 2. Diagnosed with stages 1-3 of chronic kidney disease of unknown origin, as determined by
  • Albuminuria (ACR >30 mg/g)
  • Decreased GFR
  • Lower serum levels of liver enzymes
  • Increased Beta-2 microglobulin (B2M) concentration
  • Low serum bilirubin level

排除标准

  • 1. Patients with renal insufficiency with a potentially reversible cause such as: malignant hypertension, urinary tract infection, hypercalcemia, drug-induced nephrotoxic effects systemic diseases such as connective-tissue diseases.
  • 2. Patients on drugs which are known to be used as antioxidants, such as Coenzyme Q10 (ubiquinone), Fish Oil (Omega – 3 polyunsaturated fatty acids), Vitamin B complex 100, Vitamin B12, Vitamin D3, Vitamin C, Vitamin E.
  • 3. Patients with Acute myocardial infarction or cerebrovascular accident in the previous 6 months.
  • 4. Patients with chronic diseases (e.g. bronchial asthma and chronic liver cell disease).
  • 5. Drug or alcohol abused Patients.
  • 6. Patients who are pregnant or breastfeeding.
  • 7. Patients who are not willing to participate in the study.
  • 8. Patients with Drug allergies.
  • 9. Patients with CKDu in stage 4 & 5.

研究者

发起方
niversity of Colombo, Sri Lanka

相似试验

Oxidative stress in Chronic Kidney Disease of... | 临床试验